Paper42226189
Pan-cancer atlas of ITGA6 unveils its multifaceted oncogenic roles and therapeutic potential in uveal melanoma.
Shi C and 7 others. BMC Cancer, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Pan-cancer atlas of ITGA6 unveils its multifaceted oncogenic roles and therapeutic potential in uveal melanoma. Papers, record 42226189. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42226189
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pan-cancer atlas of ITGA6 unveils its multifaceted oncogenic roles and therapeutic potential in uveal melanoma.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Uveal Neoplasms | Major topic |
| Melanoma | Major topic |
| Integrin alpha6 | Major topic |
| Biomarkers, Tumor | Major topic |
| Humans | |
| Uveal Melanoma | |
| Prognosis | |
| Gene Expression Regulation, Neoplastic | |
| Cell Proliferation | |
| Cell Movement | |
| Cell Line, Tumor | |
| Female |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| No.82460215 | National Natural Science Foundation Project | PubMed | ||
| No. 2024SF006 | Yinchuan Science and Technology Plan Project | PubMed | ||
| No.2024AAC03515 | Ningxia Natural Science Foundation Project | PubMed | ||
| No. XY2024058 | Ningxia Medical University School-level Scientific Research Project | PubMed |
Source PubMed
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39587240 | Prognostic and predictive value of pathohistological features in gastric cancer and identification of SLITRK4 as a potential biomarker for gastric cancer. | Sci Rep | 2024 | https://conductscience.org/library/papers/39587240 | PubMed |
| 2 | 37245545 | Integrins in cancer: Emerging mechanisms and therapeutic opportunities. | Pharmacol Ther | 2023 | https://conductscience.org/library/papers/37245545 | PubMed |
| 3 | 33785876 | Downregulation of ITGA6 confers to the invasion of multiple myeloma and promotes progression to plasma cell leukaemia. | Br J Cancer | 2021 | https://conductscience.org/library/papers/33785876 | PubMed |
| 4 | 37770930 | Integrin signaling in cancer: bidirectional mechanisms and therapeutic opportunities. | Cell Commun Signal | 2023 | https://conductscience.org/library/papers/37770930 | PubMed |
| 5 | 37444576 | Regulation and Functions of α6-Integrin (CD49f) in Cancer Biology. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37444576 | PubMed |
| 6 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 7 | 35426374 | Targeting mutations in cancer. | J Clin Invest | 2022 | https://conductscience.org/library/papers/35426374 | PubMed |
| 8 | 26524530 | Tumour exosome integrins determine organotropic metastasis. | Nature | 2015 | https://conductscience.org/library/papers/26524530 | PubMed |
| 9 | 34968869 | Invasive phenotype in triple negative breast cancer is inhibited by blocking SIN3A-PF1 interaction through KLF9 mediated repression of ITGA6 and ITGB1. | Transl Oncol | 2022 | https://conductscience.org/library/papers/34968869 | PubMed |
| 10 | 35365226 | The therapeutic potential of stem cell-derived exosomes in the ulcerative colitis and colorectal cancer. | Stem Cell Res Ther | 2022 | https://conductscience.org/library/papers/35365226 | PubMed |
| 11 | 38810731 | Age-Related Clusters and Favorable Immune Phenotypes in Young Breast Cancer Patients. | Mod Pathol | 2024 | https://conductscience.org/library/papers/38810731 | PubMed |
| 12 | 24132290 | Mutational landscape and significance across 12 major cancer types. | Nature | 2013 | https://conductscience.org/library/papers/24132290 | PubMed |
| 13 | 20885411 | Integrins as therapeutic targets: lessons and opportunities. | Nat Rev Drug Discov | 2010 | https://conductscience.org/library/papers/20885411 | PubMed |
| 14 | 32209560 | The Frequency of Ras Mutations in Cancer. | Cancer Res | 2020 | https://conductscience.org/library/papers/32209560 | PubMed |
| 15 | 29056346 | Universal Patterns of Selection in Cancer and Somatic Tissues. | Cell | 2017 | https://conductscience.org/library/papers/29056346 | PubMed |
| 16 | 35168644 | Long non-coding RNA OIP5-AS1 suppresses microRNA-92a to augment proliferation and metastasis of ovarian cancer cells through upregulating ITGA6. | J Ovarian Res | 2022 | https://conductscience.org/library/papers/35168644 | PubMed |
| 17 | 38369001 | m6A/HOXA10-AS/ITGA6 axis aggravates oxidative resistance and malignant progression of laryngeal squamous cell carcinoma through regulating Notch and Keap1/Nrf2 pathways. | Cancer Lett | 2024 | https://conductscience.org/library/papers/38369001 | PubMed |
| 18 | 30889378 | Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance. | Cancer Cell | 2019 | https://conductscience.org/library/papers/30889378 | PubMed |
| 19 | 38868713 | Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform. | Imeta | 2022 | https://conductscience.org/library/papers/38868713 | PubMed |
| 20 | 35868307 | Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer. | Cancer Cell | 2022 | https://conductscience.org/library/papers/35868307 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ITGA6 | 3655 | PubTator's text mining | https://conductscience.org/library/genes/3655 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42226189
GET https://conductscience.org/api/papers/v1/42226189/references?page=2